
IXICO PLC — Investor Relations & Filings
IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| IXICO Updates AI Neuroimaging Platform | 2026-05-12 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45118804 | IXICO Updates AI Neuroimaging Platform | 2026-05-12 | English | ||
| 38022136 | Holding(s) in Company | 2026-04-28 | English | ||
| 38012681 | Holding(s) in Company | 2026-04-28 | English | ||
| 37961295 | Holding(s) in Company | 2026-04-28 | English | ||
| 37947832 | Holding(s) in Company | 2026-04-28 | English | ||
| 37503919 | Holding(s) in Company | 2026-04-27 | English | ||
| 37503851 | Holding(s) in Company | 2026-04-27 | English | ||
| 37503840 | Holding(s) in Company | 2026-04-27 | English | ||
| 37461089 | Holding(s) in Company | 2026-04-27 | English | ||
| 37400009 | Holding(s) in Company | 2026-04-27 | English | ||
| 36162273 | Holding(s) in Company | 2026-04-24 | English | ||
| 35238680 | Issue of Equity | 2026-04-22 | English | ||
| 34696718 | Trading Update | 2026-04-21 | English | ||
| 33102062 | Retail Offer | 2026-03-31 | English | ||
| 33101907 | Placings and Subscription | 2026-03-31 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for IXICO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
|
IMV Inc.
Pioneering novel immunotherapies using the proprietary DPX®…
|
IMV | CA | Professional, scientific and te… |
|
INBIOGEN CO.,Ltd
A life sciences firm offering bioinformatics and data minin…
|
101140 | KR | Professional, scientific and te… |
|
Incannex Healthcare Inc.
A clinical-stage biopharma firm developing cannabinoid and …
|
IXHL | US | Professional, scientific and te… |
|
Indaptus Therapeutics, Inc.
Develops bacterial-based immunotherapies for cancer and vir…
|
INDP | US | Professional, scientific and te… |
IXICO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7723/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7723 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7723 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7723 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7723}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IXICO PLC (id: 7723)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.